APPROPRIATE USE OF HEPARIN - EMPIRIC VS NOMOGRAM-BASED DOSING

被引:52
作者
GUNNARSSON, PS
SAWYER, WT
MONTAGUE, D
WILLIAMS, ML
DUPUIS, RE
CAIOLA, SM
机构
[1] UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA HOSP,DEPT PHARM,CHAPEL HILL,NC
关键词
D O I
10.1001/archinte.155.5.526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A study involving two groups of patients with cardiovascular disease was conducted to compare empiric (clinician-directed) heparin therapy with therapy based on a nomogram-determined dosage. The comparison was based on (1) the average weight-referenced infusion rate yielding a therapeutic activated partial thromboplastin lime (APTT) and (2) the time required to reach a therapeutic APTT (55 to 95 seconds) after empiric or nomogram-based heparin therapy was initiated. Methods: Data were collected for patients admitted to the cardiology service at a university health science center in two phases: phase 1 (April 1 through June 30, 1992), involving 95 patients receiving heparin therapy, with 88 patients included in the data analysis, and phase 2 (March 11 through June 11, 1993), involving 156 patients receiving heparin therapy, with 45 patients receiving nomogram-guided therapy included in the data analysis. Results: In phase 1, 66 patients (75.0%) achieved a therapeutic APTT some time during their heparin therapy, with an average time to therapeutic APTT of 20.7+19.1 hours. Regression analysis demonstrated a statistically significant relationship between the heparin infusion rate at the time of the patient's first therapeutic APTT and the patient's total body weight (r(2)=.3043). An initial infusion rate based on total body weight (13 U/kg per hour) was therefore used as the basis for the nomogram in phase 2. In phase 2, 41 patients (91.1%) achieved a therapeutic APTT at some time during their heparin therapy, with an average time to therapeutic APTT of 13.1+11.9 hours, statistically significantly shorter than that in phase 1. A greater proportion of patients in phase 2 compared with patients in phase 1 reached the therapeutic range within 12 hours (62.2% vs 34.1%) and within 24 hours (77.8% vs 54.5%). Conclusions: Use of a weight-based nomogram to determine the initial and maintenance heparin infusion rates was associated with a higher percentage of patients admitted to the cardiology service reaching the targeted therapeutic APTT range at a time earlier in the course of therapy compared with empiric dosing.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 28 条
[1]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[2]   EFFECT OF INTRAVENOUS NITROGLYCERIN ON HEPARIN DOSAGE REQUIREMENTS IN CORONARY-ARTERY DISEASE [J].
BERK, SI ;
GRUNWALD, A ;
PAL, S ;
BODENHEIMER, MM .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) :393-396
[3]   EFFECT OF HEPARIN ON CORONARY ARTERIAL PATENCY AFTER THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J].
BLEICH, SD ;
NICHOLS, TC ;
SCHUMACHER, RR ;
COOKE, DH ;
TATE, DA ;
TEICHMAN, SL .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20) :1412-1417
[4]  
BRANDJES DPM, 1991, THROMB HAEMOSTASIS, V65, P703
[5]   HEPARIN KINETICS - VARIABLES RELATED TO DISPOSITION AND DOSAGE [J].
CIPOLLE, RJ ;
SEIFERT, RD ;
NEILAN, BA ;
ZASKE, DE ;
HAUS, E .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (03) :387-393
[6]  
CIPOLLE RJ, 1986, APPLIED PHARMACOKINE, P908
[7]   A STANDARD HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY [J].
CRUICKSHANK, MK ;
LEVINE, MN ;
HIRSH, J ;
ROBERTS, R ;
SIGUENZA, M .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (02) :333-337
[8]  
DEBONO DP, 1992, BRIT HEART J, V67, P122
[9]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[10]  
DuBois D, 1915, ARCH INTERN MED, V15, P868